相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genotype-guided tacrolimus dosing in African-American kidney transplant recipients
K. Sanghavi et al.
PHARMACOGENOMICS JOURNAL (2017)
Tacrolimus population pharmacokinetics according to CYP3A5 genotype and clinical factors in Chinese adult kidney transplant recipients
H. J. Zhang et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach
Franc Andreu et al.
CLINICAL PHARMACOKINETICS (2017)
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
Elisabet Storset et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
D. J. A. R. Moes et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
Emily Brooks et al.
CLINICAL PHARMACOKINETICS (2016)
The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients
Agnieszka A. Prytula et al.
CLINICAL PHARMACOKINETICS (2016)
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Thomas Vanhove et al.
DRUG METABOLISM REVIEWS (2016)
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations
J. T. Tang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations
S. Vadcharavivad et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation
Nauras Shuker et al.
TRANSPLANT INTERNATIONAL (2016)
OPTN/SRTR 2013 Annual Data Report: kidney
A. J. Matas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation
Carlos Orlando Jacobo-Cabral et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K. A. Birdwell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique
G. A. J. van Boekel et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation
Jian-wei Yang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients
Jing-Jing Zhang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Dashboard Systems: Pharmacokinetic/Pharmacodynamic Mediated Dose Optimization for Monoclonal Antibodies
Diane R. Mould et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients (Publication with Expression of Concern. See vol. 50, pg. 1265, 2020)
LiQin Zhu et al.
XENOBIOTICA (2015)
Population Pharmacokinetic-Pharmacogenetic Model of Tacrolimus in the Early Period after Kidney Transplantation
Nayoung Han et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Population-based meta-analysis of furosemide pharmacokinetics
Scott A. Van Wart et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients
Mariam H. Abdel Jalil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients
Nastya Kassir et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks
Laure Elens et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
Elisabet Storset et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's Perspective
Kris M. Jamsen et al.
CLINICAL PHARMACOKINETICS (2014)
The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation
Dennis A. Hesselink et al.
CLINICAL PHARMACOKINETICS (2014)
Importance of hematocrit for a tacrolimus target concentration strategy
Elisabet Storset et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Methods to detect non-compliance and reduce its impact on population PK parameter estimates
Leonid Gibiansky et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation
Teun van Gelder et al.
NATURE REVIEWS NEPHROLOGY (2014)
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach
Vanessa Guy-Viterbo et al.
PHARMACOGENOMICS (2014)
Population Pharmacokinetics of Cyclosporine in Transplant Recipients
Kelong Han et al.
AAPS JOURNAL (2013)
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
R. Bouamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Population-based meta-analysis of hydrochlorothiazide pharmacokinetics
Scott A. Van Wart et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients
Ken Ogasawara et al.
CLINICAL PHARMACOKINETICS (2013)
Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients
Nayoung Han et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction
Itziar Oteo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients
Wei Zhao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation
V. Guy-Viterbo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics of tacrolimus in kidney transplant patients
R. Velickovic-Radovanovic et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Tacrolimus dose individualization in de novo patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology
Naiara Valdivieso et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
From gut to kidney: Transporting and metabolizing calcineurin-inhibitors in solid organ transplantation
Noel Knops et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
Xiao-cong Zuo et al.
PHARMACOGENETICS AND GENOMICS (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Anders Asberg et al.
TRANSPLANT INTERNATIONAL (2013)
Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs
P. A. Jacobson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung Transplantation
Caroline Monchaud et al.
CLINICAL PHARMACOKINETICS (2012)
The Impact of Sulfonylureas on Tacrolimus Apparent Clearance Revealed by a Population Pharmacokinetics Analysis in Chinese Adult Liver-Transplant Patients
Xiao-qing Zhang et al.
THERAPEUTIC DRUG MONITORING (2012)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development
D. R. Mould et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2012)
Dosing equation for tacrolimus using genetic variants and clinical factors
Chaitali Passey et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®
Jean-Baptiste Woillard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Need for Standardization of Tacrolimus Assays
Daniel M. Levine et al.
CLINICAL CHEMISTRY (2011)
Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis
X. -J. Shi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation
Daniel F. B. Wright et al.
PHARMACEUTICAL RESEARCH (2011)
Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in Healthy Chinese Volunteers
Ling Xue et al.
PHARMACOLOGY (2011)
Population Pharmacokinetics of Tacrolimus in Pediatric Liver Transplantation: Early Posttransplantation Clearance
Johan E. Wallin et al.
THERAPEUTIC DRUG MONITORING (2011)
Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2010)
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
Christine E. Staatz et al.
CLINICAL PHARMACOKINETICS (2010)
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation
Arnaud Capron et al.
PHARMACOGENOMICS (2010)
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2009)
Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
W. Zhao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients
Rogier R. Press et al.
THERAPEUTIC DRUG MONITORING (2009)
Population Pharmacokinetics of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Recipients: New Initial Dosage Suggestions and a Model-Based Dosage Adjustment Tool
Johan E. Wallin et al.
THERAPEUTIC DRUG MONITORING (2009)
Time of Drug Administration, CYP3A5 and ABCB1 Genotypes, and Analytical Method Influence Tacrolimus Pharmacokinetics: A Population Pharmacokinetic Study
Flora Tshinanu Musuamba et al.
THERAPEUTIC DRUG MONITORING (2009)
New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation
Hylke de Jonge et al.
THERAPEUTIC DRUG MONITORING (2009)
Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
The role of tacrolimus in renal transplantation
Lyndsey J. Bowman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
D. Li et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated?: A survey of the literature from 2002 to 2004
Karl Brendel et al.
CLINICAL PHARMACOKINETICS (2007)
Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics
Kazuhide Iwasaki
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients
Masahide Fukudo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients
Ju Yeun Lee et al.
PHARMACOTHERAPY (2006)
Population pharmacokinetics of tacrolimus in whole blood and plasma in Asian liver transplant patients
WJ Sam et al.
CLINICAL PHARMACOKINETICS (2006)
Beyond cyclosporine: A systematic review of limited sampling strategies for other immunosuppressants
Lillian S. L. Ting et al.
THERAPEUTIC DRUG MONITORING (2006)
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance
M Antignac et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
CE Staatz et al.
CLINICAL PHARMACOKINETICS (2004)
Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation
M Fukudo et al.
CLINICAL PHARMACOKINETICS (2003)
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients
CE Staatz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants
CE Staatz et al.
TRANSPLANTATION (2001)
Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy
MJG Sanchez et al.
CLINICAL PHARMACOKINETICS (2001)
Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients
WJ Sam et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
